A cationic polymeric prodrug with chemotherapeutic self-sensibilization co-delivering MMP-9 shRNA plasmid for a combined therapy to nasopharyngeal carcinoma. This evidence concerns the gene MMP9 and nasopharyngeal carcinoma.